Buprenorphine Implants for Treatment of Opioid Dependence: A Randomized Controlled Trial [Original Contribution]
Buprenorphine Implants for Treatment of Opioid Dependence: A Randomized Controlled Trial [Original Contribution]
Context Limitations of existing pharmacological treatments for opioid dependence include low adherence, medication diversion, and emergence of withdrawal symptoms. Objective To determine the efficacy of buprenorphine implants that provide a low, steady level of buprenorphine… Continue reading
Use of Nicotine Replacements in Tobacco Dependence
Host Bill Paxton, Pine Rest Director of Northern Michigan Services interviews Chuck Bethea LMSW, PhD about the use of nicotine replacements in tobacco dependence. This clip is from the local television show Restoring Lives, Renewing Spirits.
Video Rating: 0 / 5
Implanting medication to treat opioid dependence appears beneficial in decreasing opioid usage
Implanting medication to treat opioid dependence appears beneficial in decreasing opioid usage
( JAMA and Archives Journals ) Helping to address the issue of medication adherence, persons with opioid dependence who had the medication buprenorphine implanted had less opioid use over 16 weeks, according to a study in the Oct.… Continue reading
Implanting Medication to Treat Opioid Dependence Beneficial in Decreasing Opioid Usage
Implanting Medication to Treat Opioid Dependence Beneficial in Decreasing Opioid Usage
Helping to address the issue of medication adherence, persons with opioid dependence who had the medication buprenorphine implanted had less opioid use over 16 weeks, according to a study in the October 13 issue of JAMA.
Read more on Newswise
Lohan treated for ‘cocaine dependence’
Lohan treated for ‘cocaine dependence’
Lindsay Lohan is reportedly being treated for cocaine addiction in Los Angeles.
Read more on Sky News Australia
Princess Leia did cocaine on Star Wars set
ACTRESS Carrie Fisher tells of drug culture behind the scenes of The Empire Strikes Back.
Read more on Daily Telegraph
The Partnership at Drugfree.org Comments on FDA Approval of Alkermes Opioid Dependence Medication
The Partnership at Drugfree.org Comments on FDA Approval of Alkermes Opioid Dependence Medication
Statement of Steve Pasierb, President NEW YORK, Oct. 13 /PRNewswire-USNewswire/ — The U.S. Food and Drug Administration’s approval of Alkermes’ opioid dependence medication (VIVITROL) for the prevention of relapse to opioid dependence following opioid detoxification is positive… Continue reading →